Decision Summary
Recommendation, implication, confidence, material risk, and next action.
SAMPLE OUTPUT
A decision artifact with the reasoning still attached.
The sample shows the structure of an anonymized, clinically reviewed output—not a client case, live patient record, or executable recommendation.
What the product looks like.
The output is arranged around the decision owner's next move, with evidence status and uncertainty visible at the point of use.
Site + PI Intelligence
Prioritized candidates, rationale, protocol fit, supporting evidence, and conflicts.
Evidence & Review Trail
Source, date, cohort, method, evidence status, reviewer status, and unknowns.
Validation Plan
The calls, feasibility questions, and evidence needed before the next commitment.
ILLUSTRATIVE / ANONYMIZEDONCOLATTICE / DECISION OUTPUT
DECISION QUESTION
Which candidate geographies deserve sponsor and CRO diligence first for this protocol?
Advance two convergent priorities; hold one public-signal candidate pending clinical validation; diligence one incremental signal surfaced by the independent model.
2 / reinforce1 / challenge1 / reveal
- Public trial + exact-site graph
- PI affiliation + protocol-fit review
- Competitive burden + temporal signal
- Licensed clinical layer / if permitted
Moderate — entity and clinical review complete; forward-looking feasibility pending.
Validate patient pool, PI bandwidth, activation capacity, and competing-trial load with sponsor and CRO teams.
Illustrative anonymized reconstruction based on the structure of a public-evidence analysis. No client, asset, site, investigator, patient, non-public information, or executable recommendation is shown.
START WITH ONE DECISION
A focused pilot begins with a fixed question.
The first engagement is designed to produce an independent signal that can be compared with the sponsor's or CRO's current view.
Outputs are for strategic planning and do not guarantee patient availability, enrollment, site performance, regulatory outcomes, or clinical success.